To clarify the preventive effect of OCA on NASH development, we performed a microarray analysis of livers from the vehicle- and OCA (10 mg/kg)-treated MC4R-KO mice. This evidence concerns the gene MC4R and metabolic dysfunction-associated steatohepatitis.